Huan Qiu Wang Zi Xun·2025-11-16 04:05Core Points - A California federal jury ruled that Apple infringed on Masimo's patents related to blood oxygen detection technology in the Apple Watch, ordering Apple to pay approximately $634 million in damages [1][3] - Apple plans to appeal the ruling, while Masimo views the decision as a significant victory for protecting its innovations and intellectual property [1] Legal Disputes - The ruling is part of a long-standing patent dispute, with Masimo previously accusing Apple of poaching key employees and misappropriating pulse oximetry technology for the Apple Watch [3] - In 2023, the U.S. International Trade Commission (ITC) found Apple guilty of infringement, leading to an import ban on the Apple Watch Series 9 and Ultra 2 [3] - To comply with the import ban, Apple temporarily removed the blood oxygen detection feature from its products until a revised version was approved by U.S. Customs and Border Protection in August [3] Ongoing Legal Proceedings - The ITC announced it will initiate a new process to review whether the updated Apple Watch still falls under the import ban [3] - Masimo's lawsuit regarding the customs approval decision is still pending, and Apple has appealed the previous import ban to the federal appeals court [3] - The companies have engaged in multiple legal battles, including a failed commercial secrets lawsuit in California in 2023 and a symbolic $250 judgment in Delaware in 2024 favoring Apple [3]